Obstructive sleep apnoea affects an estimated one billion people globally and is substantially underdiagnosed, carrying implications for cardiovascular risk, metabolic health, and daytime function. Continuous positive airway pressure remains the most effective treatment, though adherence is a persistent challenge. Mandibular advancement devices, upper airway surgery, and hypoglossal nerve stimulation expand options for CPAP-intolerant patients.
Loading articles...
